Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	14.47	16.59	22.79	24.61	23.14
Depreciation & Amortization	12.12	9.22	7.21	6.31	8.8
Loss (Gain) From Sale of Assets	-	-	-	-	-0.2
Other Operating Activities	0.28	-1.28	-0.73	0.41	-0.61
Change in Accounts Receivable	5.97	-0.93	-3.86	0.34	0.73
Change in Inventory	-15.68	-0.01	-1.54	-8.59	1.43
Change in Accounts Payable	-2.83	4.12	-5.73	3.77	0.72
Change in Unearned Revenue	-5.14	-1.89	-1.07	1.27	-0.83
Change in Other Net Operating Assets	-5.95	-0.79	-1.66	0.36	-0.25
Operating Cash Flow	3.24	25.05	15.42	28.49	32.93
Operating Cash Flow Growth	-87.08%	62.50%	-45.90%	-13.47%	-16.19%
Capital Expenditures	-13.02	-14.59	-1.4	-0.09	-1.1
Sale of Property, Plant & Equipment	-	-	-	-	0.2
Sale (Purchase) of Intangibles	-0.11	-	-	-0.17	-
Investment in Securities	18.59	4.4	-27.52	12.47	-9.49
Other Investing Activities	-0.2	-0.4	1.58	-1.59	-0.59
Investing Cash Flow	5.26	-10.6	-27.34	10.62	-10.97
Long-Term Debt Repaid	-2.72	-2.65	-2.58	-2.76	-2.71
Net Debt Issued (Repaid)	-2.72	-2.65	-2.58	-2.76	-2.71
Common Dividends Paid	-14.63	-16.17	-20.79	-19.25	-17.71
Financing Cash Flow	-17.35	-18.82	-23.37	-22.01	-20.42
Net Cash Flow	-8.86	-4.37	-35.29	17.1	1.53
Free Cash Flow	-9.79	10.46	14.02	28.4	31.83
Free Cash Flow Growth	-	-25.42%	-50.63%	-10.78%	-12.12%
Free Cash Flow Margin	-5.52%	6.11%	7.76%	14.68%	17.43%
Free Cash Flow Per Share	-0.63	0.68	0.91	1.84	2.06
Cash Interest Paid	0.18	0.25	0.33	0.06	0.1
Cash Income Tax Paid	2.18	5.02	5.24	5.39	5.54
Levered Free Cash Flow	-16.22	3.39	14.95	23.7	30.74
Unlevered Free Cash Flow	-16.11	3.54	15.15	23.73	30.8
Change in Working Capital	-23.64	0.52	-13.86	-2.85	1.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.